Ichor Life Sciences Invests $1.5 Million in MitoChem Therapeutics for Ocular Aging Disease Research
LAFAYETTE, NY / ACCESSWIRE / August 15, 2022 / Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in
Source: einnews.com